title: Biologic Therapeutic Drug Monitoring in Australia.
authors.affiliation: IBD Service, Department of Gastroenterology, Liverpool Hospital, Liverpool, New South Wales, Australia. susan.connor2@sswahs.nsw.gov.au.|South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Australia. susan.connor2@sswahs.nsw.gov.au.
authors.forename: Susan
authors.initials: S
authors.lastname: J Connor
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage* / Q000378:metabolism*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001315:Australia; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000378:metabolism*; D003424:Crohn Disease / Q000188:drug therapy* / Q000378:metabolism*; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D000069285:Infliximab / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C543529:vedolizumab; D000069285:Infliximab; D000068879:Adalimumab